Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001217858 | SCV001389716 | uncertain significance | Hereditary motor and sensory neuropathy, Okinawa type; Spastic paraplegia 57, autosomal recessive | 2019-11-11 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with serine at codon 326 of the TFG protein (p.Ala326Ser). The alanine residue is weakly conserved and there is a moderate physicochemical difference between alanine and serine. This variant is present in population databases (rs776620173, ExAC 0.1%). This variant has not been reported in the literature in individuals with TFG-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |